Mercado de gestión de dosis de radiación: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPHE100001217
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 206
Buy Now

Se prevé que el mercado de gestión de dosis de radiación alcance los 646,87 millones de dólares en 2028, frente a los 270,32 millones de dólares de 2021; se estima que crecerá a una tasa compuesta anual del 13,3 % durante 2021-2028.

La radioterapia es una rama esencial de la ciencia médica. Diversas enfermedades como el cáncer, las enfermedades cardiovasculares, etc. se diagnostican y tratan mediante ondas electromagnéticas. Se utiliza ampliamente para tratar diferentes tipos de cáncer. Sin embargo, la radioterapia también tiene efectos secundarios. Por lo tanto, controlar la dosis de radiación correcta es muy esencial en cualquier procedimiento médico basado en radiación. La dosis de radiación es la cantidad de radiación que se arroja al paciente. La gestión de dosis de radiación comprende información sobre software de registro de dosis de radiación; monitoreo de dosis del personal en tiempo real; Cumplimiento normativo; y tecnologías de reducción de dosis, como software de reconstrucción interactiva.

El crecimiento del mercado de gestión de dosis de radiación se atribuye a las crecientes preocupaciones relacionadas con la exposición a la radiación y al aumento de los casos de cáncer que requieren radioterapia. Sin embargo, los desafíos organizativos y la falta de evaluaciones comparativas para la optimización de dosis obstaculizan el crecimiento del mercado.    

Perspectivas estratégicas

regiones lucrativas en el mercado de gestión de dosis de radiación

  ;

Perspectivas del mercado

Creciente enfoque en la radiología intervencionista y la medicina nuclear

Rápidos avances en tecnología médica, fabricación de dispositivos y equipos de imágenes han resultado en el perfeccionamiento de procedimientos originales con mejores técnicas y una ampliación de las indicaciones de los procedimientos. Se han desarrollado nuevas técnicas y algunas técnicas se migran a otras modalidades de imagen. Debido a la alta eficiencia de las imágenes, en todo el mundo se están realizando más procedimientos de medicina nuclear y radiológica intervencionista. Según la Sociedad de Medicina Nuclear, cada año se realizan aproximadamente 20 millones de procedimientos de medicina nuclear en los EE. UU. Según informa la Asociación Nuclear Mundial, más de 10.000 hospitales en todo el mundo utilizan radioisótopos en medicina y el 90% de los procedimientos con radioisótopos son de diagnóstico. Actores del mercado como Bayer Healthcare y Sectra Medical Systems ofrecen software de gestión de dosis específicamente para RDM en imágenes intervencionistas y medicina nuclear. Por lo tanto, el creciente enfoque en la radiología intervencionista y la medicina nuclear está brindando oportunidades para el crecimiento del mercado.

Información basada en servicios/software

Basado en servicios/software, el mercado mundial de gestión de dosis de radiación se ha segmentado en servicios de gestión de dosis de radiación y software de gestión de dosis de radiación. El segmento de software de gestión de dosis de radiación tuvo la mayor participación del mercado en 2021 y se prevé que registre una tasa compuesta anual del 13,6% en el mercado durante el período de pronóstico.   

Mercado de gestión de dosis de radiación, por servicio/software: 2021 y 2028

Perspectivas basadas en medios

Según el medio, el mercado mundial de gestión de dosis de radiación se segmenta en tomografía computarizada, radiación y mamografía, fluoroscopia y mamografía, y otros medios. El segmento de tomografía computarizada tuvo la mayor participación del mercado en 2021 y se prevé que registre una tasa compuesta anual del 13,8% en el mercado durante el período de pronóstico.

Usuario final: Información basada en

Según el usuario final, el mercado de gestión de dosis de radiación está segmentado en hospitales, institutos médicos y de investigación, entre otros. El segmento hospitalario tuvo la mayor participación del mercado en 2021 y se estima que registrará la CAGR más alta del mercado del 13,6% durante el período de pronóstico.

Lanzamientos de productos y Las aprobaciones son estrategias comúnmente adoptadas por las empresas para expandir su presencia global y carteras de productos. Además, los actores del mercado de gestión de dosis de radiación se centran en la estrategia de asociación para ampliar su clientela, lo que, a su vez, les permite mantener su marca en todo el mundo.

Perfiles de la empresa

  • FUJIFILM Holdings Corporation
  • Bayer AG
  • Bracco Imaging SpA
  • GE Healthcare
  • < li>Koninklijke Philips NV
  • Medsquare
  • Novarad Corporation
  • QAELUM INC
  • Sectra AB
  • PACSHealth, LLC
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the radiation dose management market?

The radiation dose management market majorly consists of the players such as FUJIFILM Holdings Corporation; Bayer AG; Bracco Imaging S.p.A; GE Healthcare; Koninklijke Philips N.V.; Medsquare; Novarad Corporation; QAELUM INC; Sectra AB; PACSHealth, LLC: among others.

What is the regional market scenario of radiation dose management?

Global radiation dose management market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for radiation dose management. The market growth in the country is attributed to the factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies, and the presence of stringent regulatory requirements regarding patient safety. And, North America is the fastest-growing region growing at the CAGR of 13.8% during the forecast period.

Which End user held the largest share in the radiation dose management market?

The hospitals segment dominated the global radiation dose management market and accounted for the largest revenue share of 51.14% in 2021.

Which medium held the largest share in the radiation dose management market?

The Computed Tomography segment dominated the global radiation dose management market and held the largest revenue share of 42.54% in 2021.

What is radiation dose management?

Radiation dose management involves services and software that keep records of the radiation doses, real time dose monitoring, regulatory compliance. It is an information technology which is considerate in lowering the dose with integrative reconstruction software. The software assists to find the right way to radiation dose for a patient to get treated by the integration of medical technology and insightful data & services.

What are the driving factors for the radiation dose management market across the globe?

Key factors that are driving the growth of this market are growing concerns related to radiation exposure, and rising cases of cancer demanding radiation therapy.

Which service or software held the largest share in the radiation dose management market?

The Radiation Dose Management software segment dominated the global radiation dose management market and held the largest revenue share of 77.67% in 2021.

List of Companies - Radiation Dose Management Market           

  1. FUJIFILM Holdings Corporation
  2. Bayer AG
  3. Bracco Imaging S.p.A
  4. GE Healthcare
  5. Koninklijke Philips N.V.
  6. Medsquare
  7. Novarad Corporation
  8. QAELUM INC
  9. Sectra AB
  10. PACSHealth, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports